to Test the Hypothesis That NHFOV is More Effective Than nCPAP in the Treatment of Respiratory Distress Syndrome (RDS) in Verypreterm Neonates
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| NHFOV as Primary Support in Very Preterm Infants With RDS (NCT05141435) | Jiulongpo No.1 People's Hospital | 2022-08-01 |
Track to Test the Hypothesis That NHFOV is More Effective Than nCPAP in the Treatment of Respiratory Distress Syndrome (RDS) in Verypreterm Neonates automatically
Every clearance here is in the API, with alerts when new ones post.